本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Janux Therapeutics, Inc.

15.82
+0.63004.15%
盤後15.51-0.3100-1.96%18:18 EDT
成交量:114.83萬
成交額:1,799.73萬
市值:9.62億
市盈率:-8.63
高:15.85
開:15.33
低:15.33
收:15.19
52周最高:35.34
52周最低:12.12
股本:6,083.17萬
流通股本:4,168.06萬
量比:1.42
換手率:2.75%
股息:- -
股息率:- -
每股收益(TTM):-1.8336
每股收益(LYR):-1.8336
淨資產收益率:-11.48%
總資產收益率:-9.55%
市淨率:1.01
市盈率(LYR):-8.63

資料載入中...

2024/09/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/09

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/07

重要事件披露

Form 8-K - Current report
2024/07/22

重要事件披露

Form 8-K - Current report
2024/06/28

重要事件披露

Form 8-K - Current report
2024/06/05

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/06/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities